Omalizumab management beyond clinical trials: the added value of a network model

M Caminati, G Senna, FC Bianchi, MR Marchi… - Pulmonary …, 2014 - Elsevier
Background Omalizumab is effective and safe in severe allergic asthma. Few data are
available about its impact on lung function and on asthma comorbidities, long-term follow-up …
被引用次数：23 相关文章
[PDF] academia.edu

[PDF][PDF] Omalizumab management beyond clinical trials: The added value of a network model

M Caminati, G Senna, FC Bianchi… - Pulmonary …, 2014 - academia.edu
abstract Background: Omalizumab is effective and safe in severe allergic asthma. Few data
are available about its impact on lung function and on asthma comorbidities, long-term …

Omalizumab management beyond clinical trials: the added value of a network model

M Caminati, G Senna, FC Bianchi… - Pulmonary …, 2014 - pubmed.ncbi.nlm.nih.gov
Background Omalizumab is effective and safe in severe allergic asthma. Few data are
available about its impact on lung function and on asthma comorbidities, long-term follow-up …

[引用][C] Omalizumab management beyond clinical trials: The added value of a network model

M Caminati, G Senna, F Chieco Bianchi… - PULMONARY …, 2014 - research.unipd.it

Omalizumab management beyond clinical trials: the added value of a network model.

M Caminati, G Senna, MR Marchi… - Pulmonary …, 2014 - europepmc.org
Background Omalizumab is effective and safe in severe allergic asthma. Few data are
available about its impact on lung function and on asthma comorbidities, long-term follow-up …

Omalizumab management beyond clinical trials: the added value of a network model

M Caminati, G Senna, F Chieco Bianchi… - PULMONARY …, 2014 - iris.univr.it
Background: Omalizumab is effective and safe in severe allergic asthma. Few data are
available about its impact on lung function and on asthma comorbidities, long-term follow-up …

Omalizumab management beyond clinical trials: The added value of a network model

M Caminati, G Senna, FC Bianchi, MR Marchi… - Pulmonary …, 2014 - infona.pl
Omalizumab is effective and safe in severe allergic asthma. Few data are available about its
impact on lung function and on asthma comorbidities, long-term follow-up of treated patients …
[PDF] academia.edu

[PDF][PDF] Omalizumab management beyond clinical trials: The added value of a network model

M Caminati, G Senna, FC Bianchi… - Pulmonary …, 2014 - academia.edu
abstract Background: Omalizumab is effective and safe in severe allergic asthma. Few data
are available about its impact on lung function and on asthma comorbidities, long-term …